Am.  Jour.  Pharm. )  American  Pharmaceutical  Association.  4s 
January,  1911.     j  ~-' 
manner,  and  so  forth,  all  the  way  down  to  hiring  and  firing  help 
and  standing  off  the  dissatisfied  co-boss  and  the  cantankerous  adver- 
tiser or  contributor.  Such  a  man  is  rare  and  is  nascitur  nan  fit,  and 
he  has  yet  to  go  through  a  course  of  training  to  develop  his  technic 
at  that." 
The  importance  of  this  one  question  alone,  the  imperative  need 
of  securing  for  the  prospective  Journal  an  editor  who  is  independent, 
efficient,  fearless,  and  competent,  would  appear  to  your  committee 
to  be  a  sufficiently  valid  reason  for  deferring  the  publication  of  the 
new  Journal  from  July  i,  191 1,  to  January  i,  1912,  so  as  to  give 
the  members  of  the  Council  of  the  Am. Ph. A.  ample  opportunity  to 
canvass  all  of  the  several  candidates,  and  to  select  from  among  them 
the  one  man  most  capable  of  meeting  the  requirements  so  tersely 
outlined  above. 
In  addition  to  this  self-evident  reason  for  delaying  the  publica- 
tion of  the  initial  number  of  the  proposed  Journal,  your  committee 
would  point  out  that  there  are  a  number  of  other  reasons,  any  one 
of  which  should  suffice  to  cause  the  Council  of  the  Am. Ph. A.  seri- 
ously to  consider  the  advisability  of  deferring  publication  of  the 
Journal  until  after  the  meeting  of  the  American  Pharmaceutical 
Association,  in  August,  191 1.  In  order  that  this  report  may  not 
exceed  reasonable  limits,  but  a  few  of  these  reasons  may  be  men- 
tioned and  they  but  briefly : 
For  very  practical  reasons,  it  is  advantageous  to  begin  and  end 
a  volume  of  a  periodical  with  the  calendar  year.  The  importance 
of  this  consideration  is,  perhaps,  best  appreciated  by  librarians  and 
compilers,  but  even  the  casual  reader  must  recognize  the  possibility 
of  irritating  mistakes  and  serious  delays  caused  by  incomplete  refer- 
ences to  articles  in  journals  covering  a  portion  of  two  calendar 
years. 
The  outline  of  the  scope  of  the  prospective  Journal,  as  presented 
for  the  committee  in  the  article  referred  to  your  committee,  is  alto- 
gether too  general  to  be  seriously  considered  by  any  association  hav- 
ing the  ideals  and  the  aims  of  the  American  Pharmaceutical  Associa- 
tion. The  scope  of  the  Journal,  as  thus  outlined,  would  permit  of  a 
vacillating  policy  on  the  part  of  the  editor  or  the  committee  on  publi- 
cation, both  as  to  the  reading  matter  and  as  to  the  kind  and  character 
of  the  advertising  matter  that  is  to  be  accepted. 
In  the  opinion  of  your  committee,  the  Council  of  the  Association 
should  also  define  the  responsibility  for  material  appearing  in  the 
reading  pages  of  the  Journal.    We  would  suggest  that  it  require 
